Corient Private Wealth LLC Buys 64,926 Shares of Colgate-Palmolive Company $CL

Corient Private Wealth LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 13.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 541,110 shares of the company’s stock after purchasing an additional 64,926 shares during the period. Corient Private Wealth LLC’s holdings in Colgate-Palmolive were worth $42,789,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the stock. Teacher Retirement System of Texas boosted its stake in shares of Colgate-Palmolive by 35.3% in the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock valued at $37,110,000 after purchasing an additional 122,634 shares during the last quarter. Citigroup Inc. grew its position in shares of Colgate-Palmolive by 43.7% during the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock worth $107,646,000 after buying an additional 409,710 shares during the period. GAMMA Investing LLC raised its stake in shares of Colgate-Palmolive by 114.2% during the fourth quarter. GAMMA Investing LLC now owns 23,329 shares of the company’s stock worth $1,843,000 after buying an additional 12,437 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC raised its stake in shares of Colgate-Palmolive by 217.0% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock worth $3,246,000 after buying an additional 27,796 shares during the last quarter. Finally, Avior Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $1,135,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.3%

Shares of NYSE CL opened at $89.74 on Monday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The stock has a market cap of $71.81 billion, a P/E ratio of 34.92, a P/E/G ratio of 4.72 and a beta of 0.33. The firm has a 50 day moving average price of $87.40 and a 200 day moving average price of $86.65.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the business posted $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Analysts Set New Price Targets

CL has been the topic of a number of recent research reports. Barclays raised their price objective on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 5th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 8th. Piper Sandler cut their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $99.00 price objective on shares of Colgate-Palmolive in a research note on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.